Previous studies have found that macrophage inhibitory factor (MIF) gene polymorphisms and serum MIF and MIF mRNA levels are significantly higher in vitiligo patients than in healthy people, which was consistent with our results (Oiso et al., 2013; Farag et al., 2018; Garcia-Orozco et al., 2020). The gene discussed is MIF; the disease is vitiligo.